City view Singapore by night (Photo by Aleksandra Pachecka from Shutterstock.com).

The electricity tariffs will increase by an average of 2.1% or 0.48 cent per kWh for the period from 1 October to 31 December 2018 compared to the previous quarter, mainly due to the higher cost of natural gas for electricity generation compared to the previous quarter.

In a press release on Saturday (30 September), SP Group stated that for households, the electricity tariff will increase from 23.65 to 24.13 cents per kWh for 1 October to 31 December 2018. While, the average monthly electricity bill for families living in four-room HDB flats will increase by $1.76.

SP Group stated that it reviews the electricity tariffs quarterly based on guidelines set by the Energy Market Authority (EMA), the electricity industry regulator.

On 21 September, Energy Market Authority (EMA) had announced that the Open Electricity Market (OEM) will be extended to all consumers across Singapore by zones starting from 1 November 2018.

The authority noted that OEM gives consumers more choice and flexibility when buying electricity, while being provided with the same electricity supply through the national power grid.

Consumers can buy electricity from any of the 12 authorised retailers, which are Best Electricity Pte Ltd, Environmental Solutions (Asia) Pte Ltd, Geneco (by Seraya), ISwitch Pte Ltd, Keppel Electric Pte Ltd, Ohm Energy Pte Ltd, PacificLight Energy Pte Ltd, Sembcorp Power Pte Ltd, Senoko Energy Pte Ltd, SingNet Pte Ltd, Tuas Power Supply Pte Ltd, and Union Power Pte Ltd.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Temasek Holdings’ Letter to Temasek Review

The following letter was sent by the Senior Managing Director and Head…

Prof Donald Low calls out Singaporeans for 'petitionary culture' following mum who complained that PSLE was a nightmare

Days after the mathematics paper of the Primary School Leaving Examination (PSLE),…

累计确诊67起 今本地再增9起新病例创新高

卫生部今日(14日)证实,本地再增加九起确诊病例,创下单日新高。其中六位病患和神召会恩典堂有关。 目前该社区感染群已有13人被感染,包括教堂职员。此前该教堂牧师赵克文也证实自己是确诊病患之一。 我国当前全国累计确诊病例已增至67起,不过与此同时再有两人康复出院(累计17人康复出院),仍有六人病况危急,须在加护病房接受治疗。 公用事业局职员确诊感染 今早环境大厦传出疑似病例,部分员工被撤离。如今公用事业局发文告证实,其中一名职员确诊,受影响楼层70名员工需撤离公司,远程办公。 不过,卫生部长颜金勇表示,当局目前仍未计划提升警戒级别至红色。  

致癌物NMBA含量超标 卫生局回收三种氯沙坦药物

卫生科学局(HSA)宣布召回三款含氯沙坦(losartan)的治高血压药物:Hyperten、Losagen和Losartas,理由是这些药物中,含有超过国际标准的亚硝酸胺(NMBA)致癌污染物质。 根据卫生部今日(28日)发出的文告,这三款氯沙坦药物,是由印度药厂Hetero Labs制造,其中的致癌物质超出国际可接受的标准。 卫生部估计有13万7000名病患,目前正在使用这三款氯沙坦药物。其中有13万病患是从公共医疗机构获取Losartas牌的治高血压药。 建议勿马上停药,短期内服用不构威胁 不过,卫生科学局不建议病患马上停止服用有关药物,避免影响健康。再者,这些药物短期内不会构成健康威胁。“我们已建议医疗人员,为病患检讨和提供病患其他替代建议。” 病患若不确定自己是否受影响,宜咨询医生以提供建议。 卫生部也指出,那些来临看诊预约在今年7月1日之前的病患,应继续按照原定日期前去看病,并跟医生讨论替代药物方案;至于预约在7月1日或之后的病患,会收到通知请他们提早看病或讨论替代用药方案。 该局也指出,不是所有氯沙坦药物都被召回,我国引进的10款款氯沙坦药物中,只有上述三款含有超过我国容许标准的亚硝酸胺容量。其余七款经化验未发现亚硝酸胺。 公共医疗机构也将增加引进其他未受影响品牌的氯沙坦药物。至于那些正服用氯沙坦药物的病患,在这段期间转换治疗方案时不需支付更多费用,替代药物价格可能相同或更低。至于进行额外诊断和评估也获免除。 而病患退还上述受影响品牌的氯沙坦药物,也将获得退款。 全球高血压药回收风波…